Trial Profile
Efficacy of PENNSAID for Pain Management in the Emergency Department
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 23 Dec 2016
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary) ; Diclofenac hydroxyethylpyrrolidine
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- 11 Apr 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 08 Dec 2011 Planned end date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 08 Dec 2011 Planned initiation date changed from 1 Jun 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.